Last reviewed · How we verify
NCT06290921
Ovulation Triggering 2 vs 3 Follicles
trial testing Ovulation triggering in Infertility in 405 participants. Completed in 11 June 2024.
1 April 2024
Quick facts
| Lead sponsor | Clinique Ovo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 405 |
| Start date | 22 February 2024 |
| Primary completion | 1 April 2024 |
| Estimated completion | 11 June 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Ovulation triggering
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Clinique Ovo — full company profile →
Who can join
Adults 18 to 42, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Poor responders in in-vitro fertilization (IVF) cycles represent a major challenge for fertility specialists. Although poor responders tend to have sub-optimal fertility treatment outcomes, many of these patients wish to attempt at least one IVF cycle. Traditionally, IVF cycles producing less than 3 to 4 mature follicles (measuring at least 14 mm) have either been cancelled or converted to intra-uterine insemination (IUI) due to the low pregnancy rates associated with these cycles. The minimal number of follicles required to proceed with egg collection is based on clinical experience, having been determined by weighing the probability of implantation and pregnancy versus the risk of not obtaining quality oocytes or reaching embryo transfer when fewer mature follicles are present. This retrospective quality control study aims to compare pregnancy rates in IVF cycles producing 3 follicles measuring 14 mm and more on trigger day, versus 2 or fewer follicles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06290921
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Clinique Ovo trials
Trials by the same sponsor.
- NCT07286279 — Identifying Candidates for Limited Dissection at Microdissection TESE. · completed
- NCT07457684 — Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin · completed
- NCT07268235 — Timing of Oocyte Retrieval and Micro Testicular Sperm Extraction · completed
- NCT06502665 — Second Ovulation Induction · completed
- NCT06290895 — Artificial Oocyte Activation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06290921 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinique Ovo
- Last refreshed: 20 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06290921.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing